Account Login/Registration

Access KelownaNow using your Facebook account, or by entering your information below.


Facebook


OR


Register

Privacy Policy

BC confirms first blood clot disorder linked to AstraZeneca vaccine

Health officials confirmed BC's first case of a rare blood clot disorder following a dose of the AstraZeneca vaccine.

During a live press conference on Monday, Dr. Bonnie Henry announced that the woman in her 40s located in the Vancouver Coastal Health region is currently in stable condition and recovering in hospital.

Henry emphasized the condition is extremely rare, with research showing it affects about one in 100,000 doses.

“This is an excellent vaccine. It is safe and it is effective,” she said.

“You need to know that this disorder is rare and it is treatable and you can be confident that you have received a safe and effective vaccine.”

According to Henry, the woman noticed symptoms including a headache and swelling about five or six days after receiving a dose of AstraZeneca.

She went to her doctor, who, suspecting it might be a condition related to the vaccine, conducted a diagnostic blood test.

So far in Canada, more than 700,000 doses of the AstraZeneca shot have been administered to date, with seven reported cases of the rare clotting.

BC health officials also announced that the province will surpass two million people vaccinated at some point on Thursday.



Support local journalism by clicking here to make a one-time contribution or by subscribing for a small monthly fee. We appreciate your consideration and any contribution you can provide.


Visit our Facebook page to comment on this story.

Sign up for local eNews delivered to your inbox by 7 am every day.

Send your comments, news tips, letter to the editor, photos and videos to news@kelownanow.com.

To report a typo, send an email to news@kelownanow.com.





Wed
33℃


Thu
29℃


Fri
33℃


Sat
38℃


Sun
38℃


Mon
36℃

Top Stories

Follow Us

Follow us on Instagram Follow us on Twitter Like us on Facebook Follow us on Linkedin Follow us on Youtube Listen on Soundcloud Follow Our RSS
Privacy Policy